SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.

<h4>Background</h4>Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was...

Full description

Bibliographic Details
Main Authors: Samia A Girgis, Hala M Hafez, Hoda Ezz Elarab, Basma Sherif, Moshira H Sabry, Iman Afifi, Fatma Elzahraa Hassan, Amira Reda, Shaimaa Elsayed, Asmaa Mahmoud, Petra Habeb, Ihab S Habil, Rasha S Hussein, Isis M Mossad, Ossama Mansour, Ashraf Omar, Ayman M Saleh, Mahmoud El-Meteini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0254581
id doaj-0c2b9435a0c74056b87a98020b29afc4
record_format Article
spelling doaj-0c2b9435a0c74056b87a98020b29afc42021-08-03T04:33:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025458110.1371/journal.pone.0254581SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.Samia A GirgisHala M HafezHoda Ezz ElarabBasma SherifMoshira H SabryIman AfifiFatma Elzahraa HassanAmira RedaShaimaa ElsayedAsmaa MahmoudPetra HabebIhab S HabilRasha S HusseinIsis M MossadOssama MansourAshraf OmarAyman M SalehMahmoud El-Meteini<h4>Background</h4>Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt.<h4>Methods</h4>Our study was carried out between May 5 and the end of October 2020. It included all patients requiring admission to Ain Shams University hospitals. An interview questionnaire was used to collect demographic and clinical data. Laboratory tests for all participants included RT-PCR and total antibody assay for SARS-CoV-2.<h4>Results</h4>A total of 4,313 subjects were enrolled in our study, with females representing 56% of the sample. Adults and middle-aged individuals represented around 60% of the study sample. The positivity rate of SARS-CoV-2 PCR was 3.84% (95% CI 3.29-4.48), and the SARS-CoV-2 antibody seroprevalence was 29.82% (95% CI: 28.16-31.51). Males showed a higher risk for getting the COVID-19 infection, while middle-age group had significantly higher antibody seroprevalence rates.<h4>Conclusion</h4>SARS-CoV-2 infection imposes a high burden on the community as detected by high seroprevalence rates.https://doi.org/10.1371/journal.pone.0254581
collection DOAJ
language English
format Article
sources DOAJ
author Samia A Girgis
Hala M Hafez
Hoda Ezz Elarab
Basma Sherif
Moshira H Sabry
Iman Afifi
Fatma Elzahraa Hassan
Amira Reda
Shaimaa Elsayed
Asmaa Mahmoud
Petra Habeb
Ihab S Habil
Rasha S Hussein
Isis M Mossad
Ossama Mansour
Ashraf Omar
Ayman M Saleh
Mahmoud El-Meteini
spellingShingle Samia A Girgis
Hala M Hafez
Hoda Ezz Elarab
Basma Sherif
Moshira H Sabry
Iman Afifi
Fatma Elzahraa Hassan
Amira Reda
Shaimaa Elsayed
Asmaa Mahmoud
Petra Habeb
Ihab S Habil
Rasha S Hussein
Isis M Mossad
Ossama Mansour
Ashraf Omar
Ayman M Saleh
Mahmoud El-Meteini
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
PLoS ONE
author_facet Samia A Girgis
Hala M Hafez
Hoda Ezz Elarab
Basma Sherif
Moshira H Sabry
Iman Afifi
Fatma Elzahraa Hassan
Amira Reda
Shaimaa Elsayed
Asmaa Mahmoud
Petra Habeb
Ihab S Habil
Rasha S Hussein
Isis M Mossad
Ossama Mansour
Ashraf Omar
Ayman M Saleh
Mahmoud El-Meteini
author_sort Samia A Girgis
title SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
title_short SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
title_full SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
title_fullStr SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
title_full_unstemmed SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital.
title_sort sars-cov-2 pcr positivity rate and seroprevalence of related antibodies among a sample of patients in cairo: pre-wave 2 results of a screening program in a university hospital.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Background</h4>Research has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt.<h4>Methods</h4>Our study was carried out between May 5 and the end of October 2020. It included all patients requiring admission to Ain Shams University hospitals. An interview questionnaire was used to collect demographic and clinical data. Laboratory tests for all participants included RT-PCR and total antibody assay for SARS-CoV-2.<h4>Results</h4>A total of 4,313 subjects were enrolled in our study, with females representing 56% of the sample. Adults and middle-aged individuals represented around 60% of the study sample. The positivity rate of SARS-CoV-2 PCR was 3.84% (95% CI 3.29-4.48), and the SARS-CoV-2 antibody seroprevalence was 29.82% (95% CI: 28.16-31.51). Males showed a higher risk for getting the COVID-19 infection, while middle-age group had significantly higher antibody seroprevalence rates.<h4>Conclusion</h4>SARS-CoV-2 infection imposes a high burden on the community as detected by high seroprevalence rates.
url https://doi.org/10.1371/journal.pone.0254581
work_keys_str_mv AT samiaagirgis sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT halamhafez sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT hodaezzelarab sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT basmasherif sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT moshirahsabry sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT imanafifi sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT fatmaelzahraahassan sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT amirareda sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT shaimaaelsayed sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT asmaamahmoud sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT petrahabeb sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT ihabshabil sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT rashashussein sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT isismmossad sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT ossamamansour sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT ashrafomar sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT aymanmsaleh sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
AT mahmoudelmeteini sarscov2pcrpositivityrateandseroprevalenceofrelatedantibodiesamongasampleofpatientsincairoprewave2resultsofascreeningprograminauniversityhospital
_version_ 1721223787076124672